This document discusses the CRISPR-Cas9 genome editing technique. It begins with an introduction to CRISPR as an adaptive immune system in bacteria. The CRISPR mechanism involves acquiring DNA from invading viruses and using CRISPR RNA and Cas9 proteins to cut matching viral DNA. Scientists now use the Cas9 nuclease guided by a synthetic single guide RNA to make targeted cuts in DNA for genetic engineering. Some applications include modifying crop plants and research in mice embryos. However, using CRISPR in human embryos raises ethical concerns about germline editing and unintended consequences.